Flunixin meglumine
SIAL/Y0000443 - European Pharmacopoeia (EP) Reference Standard
Synonym: 2-
CAS Number: 42461-84-7
Empirical Formula (Hill Notation): C14H11F3N2O2·C7H17NO5
Molecular Weight: 491.46
MDL Number: MFCD01725419
Linear Formula: C14H11F3N2O2·C7H17NO5
Product Type: Chemical
API family | flunixin |
application(s) | pharmaceutical (small molecule) |
format | neat |
grade | pharmaceutical primary standard |
InChI | 1S/C14H11F3N2O2.C7H17NO5/ |
InChI key | MGCCHNLNRBULBU-WZTVWXICSA |
manufacturer/tradename | EDQM |
SMILES string | CNC[C@H](O)[C@@H](O)[C@H] |
storage temp. | 2-8°C |
Application: | Flunixin meglumine (IC50 = 1 nM) can be used as a drug for animals for the management of intestinal ischaemia, colic, and endotoxemia in horses. |
Biochem/physiol Actions: | COX1, COX2 and PLA2 inhibitor non-narcotic analgesic, anti-pyretic, anti-inflammatory. |
General description: | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia . |
Other Notes: | Sales restrictions may apply. |
Packaging: | The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue . |
Symbol | GHS07 |
Signal word | Warning |
Hazard statements | H315 - H319 - H335 |
Precautionary statements | P302 + P352 - P305 + P351 + P338 |
RIDADR | NONH for all modes of transport |
WGK Germany | WGK 3 |
Storage Temp. | 2-8°C |
UNSPSC | 41116107 |